Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1981.tb01151.x/fullpdf
Reference13 articles.
1. Three new long-acting converting enzyme inhibitors: relationship between plasma converting enzyme activity and repsonse to angiotensin I in normal volunteers;BIOLLAZ;Clin. Pharmac. Ther.,1981
2. Editorial. Inhibitors of angiotensin I converting enzyme for treating hypertension;BRITISH MEDICAL JOURNAL;Br. med. J.,1980
3. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients;BRUNNER;Ann. int. Med.,1979
4. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients;CASE;Progr. Cardiovasc. Dis.,1978
5. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensive-converting enzyme;DAVIS;New Engl. J. Med.,1979
Cited by 174 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. THE THERAPEUTIC POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ENALAPRIL TO AMELIORATE MUSCLE ATROPHY IN A MURINE MODEL;EXCLI J;2024
2. Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives;Biomedicines;2023-12-15
3. Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditions;BMC Pharmacology and Toxicology;2022-07-07
4. Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats;Biomedicine & Pharmacotherapy;2021-08
5. Pharmacology of enalapril in children: a review;Drug Discovery Today;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3